Skip to main navigation Skip to search Skip to main content

Biopolymer-based nanoparticles for cystic fibrosis lung gene therapy studies

  • Elena Fernández Fernández
  • , Beatriz Santos-Carballal
  • , Chiara De Santi
  • , Joanne Ramsey
  • , Ronan MacLoughlin
  • , Sally-Ann Cryan
  • , Catherine Greene

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

51 Citations (Scopus)

Abstract

Lung gene therapy for cystic fibrosis disease has not been successful due to several challenges such as the absence of an appropriate vector. Therefore, optimal delivery of emerging therapeutics to airway epithelial cells demands suitable non-viral systems. In this work, we describe the formulation and the physicochemical investigation of biocompatible and biodegradable polymeric nanoparticles (NPs), including PLGA and chitosan (animal and non-animal), as novel methods for the safe and efficient delivery of CFTR-specific locked nucleic acids (LNAs).
Original languageEnglish (Ireland)
JournalMaterials
DOIs
Publication statusPublished - 13 Jan 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • biopolymers
  • cell therapy
  • chitosan
  • cystic fibrosis
  • cystic fibrosis transmembrane conductance regulator (cftr)
  • disease
  • drug-delivery
  • dry powder formulations
  • in-vitro
  • locked-nucleic acid (lna)
  • lung gene delivery
  • nanoparticles
  • particle-size
  • plga
  • sirna
  • systems
  • transmembrane conductance regulator

Fingerprint

Dive into the research topics of 'Biopolymer-based nanoparticles for cystic fibrosis lung gene therapy studies'. Together they form a unique fingerprint.

Cite this